Search
forResearch 10 of 1000+
- Nanoliposomal Co-Delivery of AR-PROTAC and NFKBIZ siRNA for Synergistic Therapy of Androgenetic Alopecia
- Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Next Generation Therapeutics for Androgenetic Alopecia
- Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
- Molecular Genetic and Endocrine Mechanisms of Hair Growth
- Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
Community 10 of 58
- 1 year 5-ar. Blood test results
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- bro where tf is GT20029, Q1 2024 is over already
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- Breaking hair loss news! GT20029 is a resounding success!
- How to know if shedding is from tren or minoxidil?
- “Dutasteride destroyed my hair” recently I noticed the same users
- Creatine's effect on Hair Loss and DHT
- Dutasteride at 21 years old. Is it safe?
- AH-001 another topical AR degrader beside GT20029, completed Phase I